CCR5 and melanoma: In a spontaneous Ret transgenic mouse melanoma model, we have demonstrated that the tumor progression correlated with the accumulation of CCR5+ MDSC in the TME that displayed significantly stronger immunosuppressive capacity than their CCR5− counterpart (87).